Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Aklief" (26)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Trifarotene (D10AD06) 1 products
WHO-DDD
IP
CI
Aklief
75 g
24.84
43.45
10 %
Cream: Trifarotenum 50 µg/g
Galderma SA
B / SL
FB
G
Antiparasitic Products, Insecticides and Repellents (P) 25 products
L
IP
V/S
Shingrix
1 +
137.71
166.20
10 %
GlaxoSmithKline AG
●
B / SL
FB
G
L
IP
Ultomiris 300 mg/3 ml
4035.23
4181.20
10 %
Concentrate for infusion: Ravulizumabum 300mg / 3ml
Alexion Pharma GmbH
A / SL
FB
G
L
IP
Ultomiris 1100 mg/11 ml
14795.84
15221.60
10 %
Concentrate for infusion: Ravulizumabum 1100mg / 11ml
Alexion Pharma GmbH
A / SL
FB
G
L
IP
Dysport 500U
Flasche(n)
302.55
345.45
10 %
Ipsen Pharma Schweiz
GmbH
A / SL
FB
G
L
IP
Dysport 300U
Flasche(n)
183.74
216.25
10 %
Ipsen Pharma Schweiz
GmbH
A / SL
FB
G
IP
CI
Aklief
75 g
24.84
43.45
10 %
Cream: Trifarotenum 50 µg/g
Galderma SA
B / SL
FB
G
L
IP
Idefirix 11 mg
+ +
137798.05
141688.60
10 %
poudre pour solution à diluer pour perfusion: Imlifidasum 11 mg
iQone Healthcare
Switzerland SA
A / SL
FB
G
IP
V/S
Shingrix
10 + 10
k.A.
GlaxoSmithKline AG
B
FB
G
IP
SWAN-PSMA-1007 1 ml / 10 ml
15 ml
k.A.
SWAN Isotopen AG SWAN
Haus, Inselspital
A
FB
G
IP
CI
Nityr 2 mg
60
k.A.
Tablets: Nitisinonum 2 mg
Curatis AG
B
FB
G
IP
CI
Nityr 5 mg
60
k.A.
Tablets: Nitisinonum 5 mg
Curatis AG
B
FB
G
IP
CI
Nityr 10 mg
60
k.A.
Tablets: Nitisinonum 10 mg
Curatis AG
B
FB
G
L
IP
Ultomiris 300 mg/30 ml
4035.23
4181.20
10 %
Concentrate for infusion: Ravulizumabum 300mg / 30ml
Alexion Pharma GmbH
A / SL
FB
G
IP
Dysport 500U
2 Flasche(n)
k.A.
Ipsen Pharma Schweiz
GmbH
A
FB
G
IP
Dysport 300U
2 Flasche(n)
k.A.
Ipsen Pharma Schweiz
GmbH
A
FB
G
IP
CI
Ayvakyt 25 mg
30
k.A.
Coated tablets: Avapritinibum 25 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
CI
Ayvakyt 50 mg
30
k.A.
Coated tablets: Avapritinibum 50 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
CI
Ayvakyt 100 mg
30
k.A.
Coated tablets: Avapritinibum 100 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
CI
Ayvakyt 200 mg
30
k.A.
Coated tablets: Avapritinibum 200 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
CI
Ayvakyt 300 mg
30
k.A.
Coated tablets: Avapritinibum 300 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
CI
Jeraygo 12.5 mg
10 x 1
k.A.
Coated tablets: Aprocitentanum 12.5 mg
Idorsia
Pharmaceuticals Ltd
B
FB
G
IP
CI
Jeraygo 12.5 mg
30
k.A.
Coated tablets: Aprocitentanum 12.5 mg
Idorsia
Pharmaceuticals Ltd
B
FB
G
IP
CI
Jeraygo 25 mg
10 x 1
k.A.
Coated tablets: Aprocitentanum 25 mg
Idorsia
Pharmaceuticals Ltd
B
FB
G
IP
CI
Jeraygo 25 mg
30
k.A.
Coated tablets: Aprocitentanum 25 mg
Idorsia
Pharmaceuticals Ltd
B
FB
G
IP
Idefirix 11 mg
2
k.A.
poudre pour solution à diluer pour perfusion: Imlifidasum 11 mg
iQone Healthcare
Switzerland SA
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
